VIEMED HEALTHCARE Business Summary

Viemed Healthcare, Inc. (VMD) is a leading provider of post-acute respiratory care and technology-enabled home medical equipment, generating revenue primarily through the recurring rental and sale of high-acuity respiratory devices such as non-invasive ventilators (NIV), CPAP/BiPAP machines, and oxygen concentrators. The company’s business model is segmented into its core home respiratory therapy services, in-home sleep testing, and a growing healthcare staffing division. As of early 2026, Viemed has aggressively diversified into maternal health services, specifically breast pump distribution, following its strategic acquisition of Lehan’s Medical Equipment. In the competitive landscape, Viemed distinguishes itself from broad-line durable medical equipment (DME) providers like AdaptHealth, Lincare, and Apria Healthcare (Owens & Minor) by maintaining a high-touch clinical service model that utilizes licensed respiratory therapists to improve patient outcomes and reduce hospital readmissions, positioning it as a premium specialist compared to regional peers like Quipt Home Medical. The company was co-founded in 2006 by CEO Casey Hoyt and President Michael Moore, both of whom possess extensive backgrounds in the respiratory and durable medical equipment sectors, having scaled the firm from a regional startup to a national public entity. The executive leadership team includes Chief Operating Officer W. Todd Zehnder, who brings significant capital markets experience from his tenure at PetroQuest Energy, and Chief Financial Officer Trae Fitzgerald, who oversees the company’s financial strategy and reporting. Clinical operations are led by Chief Medical Officer Dr. William Frazier, a board-certified pulmonologist with over 30 years of experience. Viemed’s governance is supported by a seasoned board including Chairman Randy Dobbs and Nitin Kaushal, while its capital structure is characterized by high institutional ownership (~68%), with major positions held by firms such as BlackRock, Vanguard, and Apis Capital Advisors.